Around the Precinct – 24 February 2022

An Alliance expert is appointed to a state-wide COVID-19 advisory committee; new research into the effects of anti-inflammatory drugs on the kidneys; and how population genetic testing could be a cost-effective way of reducing the risk of heart disease – this week at the Alfred Research Alliance.

Monash FH genetic testing

Widespread genetic testing could help identify patients with familial hypercholesterolemia before it’s too late.

Monash University – Central Clinical School

Monash Uni stakes its claim for Moderna’s mRNA facility
Despite strong competition, Victoria has encouraged Moderna to come to its state. With the location of it’s manufacturing site looking to be confirmed by the end of April, our RNA experts provide insights into just how important choosing the right location is.
Read more

Independent expert voices to oversee pandemic response
Congratulations to Associate Professor Joseph Doyle, who has been appointed to a newly formed Independent Pandemic Management Advisory Committee (IPMAC), for his expertise in infectious diseases and public health.
Read more

New anti-inflammatory approach may damage kidneys, Monash scientists find
A study by Monash University Department of Diabetes researchers suggests that a new anti-inflammatory drug approach developed to counter inflammation and heart disease may be harmful to kidneys.
Read more

Monash University – School of Public Health and Preventive Medicine

Genetic testing for all could reduce the risk of heart disease
Population genetic screening for familial hypercholesterolemia in Australia could be cost-effective for the healthcare system.
Read more

Baker Heart and Diabetes Institute

The prevalence of heart disease among meth users – ABC RN
A smaller number of people are using methamphetamine in Australia, yet the health problems that come with it may be rising. The heart is one of the most affected organs of meth users and nearly 30% of them have an increased risk of sudden cardiac arrest due to toxic damage to the heart muscle.
Read more

‘Very overwhelming’: why can COVID impact your ability to exercise? – The Sydney Morning Herald
In March 2020, former personal trainer Matt Gardener tested positive for COVID-19. Two years on, the 36-year-old is still struggling to do basic exercise. His energy and ability to exercise, he says, “have never really come back.”
Read more

Advancing understanding of inflammation and cardiovascular disease
The ‘next frontier’ in science to stop deadly heart attacks will be the focus of the Baker Institute’s new Inflammation and Cardiovascular Disease laboratory, headed up by Dr Tin Kyaw.
Read more

Nucleus Network

In the news
Brett Favre and Jake VanLandingham from Odyssey Group speak to SEN about their clinical trial at Nucleus Network, for a novel concussion treatment.
Read more